These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 3054748)

  • 21. Clindamycin resistance in anaerobic bacteria.
    Tally FP; Cuchural GJ; Bieluch VM; Jacobus NV; Malamy MH
    Scand J Infect Dis Suppl; 1984; 43():34-43. PubMed ID: 6598519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [ESBL-positive strains of the Bacteroides fragilis group isolated from patients at the regional hospital center in Płock (Poland)].
    Rokosz A; Pawłowska J; Sawicka-Grzelak A; Luczak M
    Med Dosw Mikrobiol; 2004; 56(3):245-53. PubMed ID: 15773501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of the disc-plate method in Bacteroides fragilis].
    García Rodríguez JA; García Sánchez JE; Gómez Garciá AC; Prieto Prieto J
    Rev Clin Esp; 1977 Aug 15-31; 146(3-4):161-6. PubMed ID: 918321
    [No Abstract]   [Full Text] [Related]  

  • 24. Susceptibility trends of Bacteroides fragilis group isolates from Buenos Aires, Argentina.
    Fernández Canigia L; Castello L; Di Martino A; Greco G; Legaria MC; Litterio M; Predari SC; Rollet R; Rossetti A; Carloni G; Sarchi MI; Bianchini H
    Rev Argent Microbiol; 2007; 39(3):156-60. PubMed ID: 17987852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial susceptibility of anaerobic bacteria in Sweden in 1983.
    Nord CE; Olsson-Liljequist B
    Scand J Infect Dis Suppl; 1984; 43():44-9. PubMed ID: 6100139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular and ecological aspects of antibiotic resistance in the Bacteroides fragilis group.
    Martínez-Suárez JV; Baquero F
    Microbiologia; 1987 Oct; 3(3):149-62. PubMed ID: 3077327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Susceptibility of the Bacteroides fragilis group to 10 antibiotics. Results of 4 laboratories in Austria].
    Mittermayer H; Rotter M; Riezinger F; Thiel W; Stanek G
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Nov; 262(4):500-11. PubMed ID: 3799095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [In vitro effects of cefotetan on anaerobic bacteria of the genus Bacteroides fragilis group, in comparison with 8 antibiotics].
    Trevisan R; Proietti A; Pitzus E
    G Ital Chemioter; 1985; 32(2):367-70. PubMed ID: 3869115
    [No Abstract]   [Full Text] [Related]  

  • 29. [Bacteroides fragilis group in non-diarrheal human feces and its antimicrobial susceptibility].
    Rodríguez E; Gamboa MM; Rodríguez C; Vargas P
    Rev Esp Quimioter; 2006 Dec; 19(4):357-62. PubMed ID: 17235405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic action of erythromycin and cefamandole against Bacteroides fragilis subsp. fragilis.
    Griffith RS; Brier GL; Wolny JD
    Antimicrob Agents Chemother; 1977 May; 11(5):813-6. PubMed ID: 879736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors affecting the in vitro activity of cefoperazone against the Bacteroides fragilis group.
    Sutter VL; Kwok YY
    Antimicrob Agents Chemother; 1981 Dec; 20(6):723-5. PubMed ID: 6459765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacteroides fragilis and nitroimidazoles.
    Ferguson IR; Smith LL
    J Antimicrob Chemother; 1976 Jun; 2(2):220-1. PubMed ID: 956086
    [No Abstract]   [Full Text] [Related]  

  • 33. The activity of nitro-compounds against Bacteroides fragilis is related to their electron affinity.
    Reynolds AV
    J Antimicrob Chemother; 1981 Aug; 8(2):91-9. PubMed ID: 7275885
    [No Abstract]   [Full Text] [Related]  

  • 34. [Bacteroides fragilis meningitis. 2 cases].
    Houvenaeghel M; de Moro S; Ottomani A; Bedos B; Lallemand J; Manelli JC; Bimar J
    Presse Med; 1986 Oct; 15(33):1669-72. PubMed ID: 2947112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discrepant behaviour of clotrimazole against Bacteroides fragilis in liquid and solid media.
    Reynolds AV; Hamilton-Miller JM; Brumfitt W
    J Antimicrob Chemother; 1977 Nov; 3(6):622-4. PubMed ID: 599124
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibitory effect of fumarate on growth of Bacteroides fragilis.
    Yamamoto I; Ishimoto M
    Chem Pharm Bull (Tokyo); 1988 Dec; 36(12):5016-9. PubMed ID: 3246060
    [No Abstract]   [Full Text] [Related]  

  • 37. Comment: Association Between the Prothrombin Time-International Normalized Ratio and Concomitant Use of Antibiotics in Warfarin Users: Focus on Type of Antibiotic and Susceptibility of
    Takanashi S
    Ann Pharmacother; 2022 Jan; 56(1):108-109. PubMed ID: 34013780
    [No Abstract]   [Full Text] [Related]  

  • 38. [Formations and reactions of aromatic furazan compounds].
    Hasegawa M; Takabatake T; Miyazawa T
    Yakugaku Zasshi; 2001 Jun; 121(6):379-93. PubMed ID: 11433773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure of azomycin (2-nitro-imidazole).
    NAKAMURA S; UMEZAWA H
    J Antibiot (Tokyo); 1955 Apr; 8(2):66. PubMed ID: 13242482
    [No Abstract]   [Full Text] [Related]  

  • 40. [Influence of the inoculum effect on minimal inhibitory concentrations of 3 derivatives of 5-nitro-imidazole and 11 other antibiotics on Bacteroides fragilis].
    Dusart G; Simeon de Buochberg M; Maillols H; Zuccarelli M; Attisso MA
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):685-9. PubMed ID: 3054748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.